AiViva Biopharma

AiViva Biopharma Develop Today
To Improved Living Tomorrow
Taking on challenges of discovering therapeutics to addres

Happy New Year from AiViva BioPharma!  Wishing You Excellent Health, Success and Happiness for 2023!      needs
12/30/2022

Happy New Year from AiViva BioPharma!

Wishing You Excellent Health, Success and Happiness for 2023!

needs

Opportunity to invest in AiViva BioPharma is closing soon! Take a look at some of our company highlights! Act NOW before...
12/14/2022

Opportunity to invest in AiViva BioPharma is closing soon! Take a look at some of our company highlights!

Act NOW before it is too late!

Company Highlights:

✔️Successfully raised $30M+ and counting
✔️$10M+ Raised in 2022
✔️Protected by 23 issued patents and 40+ patents pending
✔️Diverse Clinical Pipeline focused on wet AMD, prostate disorders, and non-melanoma skin cancer

https://www.startengine.com/offering/aiviva

Don’t miss this chance to invest in an award-winning Pre-IPO biopharma company striving to help patients lead better liv...
12/12/2022

Don’t miss this chance to invest in an award-winning Pre-IPO biopharma company striving to help patients lead better lives. Invest in the future of transformative therapies.

Act NOW before it is too late!

Become a shareholder today. 👇
https://www.startengine.com/offering/aiviva

AiViva is a pre-IPO biopharma company with strong momentum. 💙 Its goal is to provide effective and convenient solutions ...
12/09/2022

AiViva is a pre-IPO biopharma company with strong momentum. 💙 Its goal is to provide effective and convenient solutions to diseases for patients and physicians.

We aim to make real changes in the way healthcare is done. Take this opportunity to invest in a company that aims to help patients with unmet medical needs Before We Close! 👇

https://www.startengine.com/offering/aiviva

Dr. Diane Tang-Liu is the co-founder and CEO of AiViva BioPharma, Inc. This award-winning Pre-IPO biopharma company focu...
12/07/2022

Dr. Diane Tang-Liu is the co-founder and CEO of AiViva BioPharma, Inc. This award-winning Pre-IPO biopharma company focuses on the development of innovative drug products to address large unmet medical needs. 💙

Her career in the pharmaceutical industry spans 35+ years! Learn more about Diane on StartEngine below. 👇
https://bit.ly/3OoiYNi

12/06/2022

AiViva’s Diverse Product Pipeline Could Have the Potential To Address Unmet Medical Needs – Read article at Yahoo Finance linked here!

Investment opportunity at StartEngine.com ending soon!
https://www.startengine.com/offering/aiviva

12/05/2022

We're a clinical stage biotech company with strong momentum. 💙 We are developing innovative treatment options to address major unmet medical needs.

“Our goal is to provide effective and convenient solutions to diseases for patients and physicians.” Dr. Diane Tang-Liu

228+ investors have joined to help change healthcare for the better. Take action and don’t miss this opportunity to join us too!

https://www.startengine.com/offering/aiviva

AiViva started with an idea: CEO Diane Tang-Liu has built AiViva around focused pharmaceutical research - research that ...
12/02/2022

AiViva started with an idea: CEO Diane Tang-Liu has built AiViva around focused pharmaceutical research - research that is making tangible impacts on a variety of medical conditions. 💙

Easier Treatment. Better Outcomes.

“Our goal is to provide effective and convenient solutions to diseases for patients and physicians.”

Diane finds it gratifying to make real, meaningful improvements in a patient's quality of life.

AiViva is a clinical stage biotech company with strong momentum.

Become a shareholder today on StartEngine! 👇
https://bit.ly/3OoiYNi

12/01/2022

Wet age-related macular degeneration is a chronic eye disorder that causes blurred vision or a blind spot in your visual field.

It's generally caused by abnormal blood vessels that leak fluid or blood and scars the macula, the area of the eye that provides the sharp, central vision needed for reading, driving, and seeing fine detail.

AiViva has a special focus on wet AMD. Our drug AIV007 addresses neovascularization, inflammation, and fibrosis (scarring) which cause vision loss for wet AMD patients. AIV007 is delivered in JEL™ to prolong the treatment duration. 💙

Become a shareholder today on StartEngine! 👇

https://bit.ly/3OoiYNi

We have much to be thankful for in 2022!   Thank you to our vendors, service providers, followers, and investors for you...
11/22/2022

We have much to be thankful for in 2022! Thank you to our vendors, service providers, followers, and investors for your support!

From All of Us at AiViva BioPharma – Have a Safe & Thanksgiving Holiday!

needs

Address

1300 Bristol Street North STE 220
Newport Beach, CA

Alerts

Be the first to know and let us send you an email when AiViva Biopharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AiViva Biopharma:

Share